In addition, the present study demonstrated that FTO expression was significantly increased in the livers of non-alcoholic steatohepatitis (NASH) patients and in a rodent model of NASH (Lim et al., 2016). The gene discussed is FTO; the disease is metabolic dysfunction-associated steatohepatitis.